Viola George M, Rolston Kenneth V, Butler Charles, Selber Jesse, Reece Gregory, Clemens Mark, Villa Mark, Raad Issam I, Baumann Donald
Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Tex.
Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex.
Plast Reconstr Surg Glob Open. 2019 Jul 26;7(7):e2342. doi: 10.1097/GOX.0000000000002342. eCollection 2019 Jul.
UNLABELLED: Several steps to reduce the rate of postoperative surgical site infections (SSIs) have been implemented. The use of prophylactic antimicrobials targeting patient's microbial flora has been associated with a decrease in postoperative infections. We evaluated the relationship between perioperative antimicrobials, baseline microbial flora, and occurrence of SSIs. METHODS: We prospectively enrolled 241 patients scheduled to receive a postmastectomy implant-based reconstructive procedure between September 2015 and January 2018. Axillary swab cultures were obtained preoperatively, and all recovered bacteria were identified. Surgeons were blinded to these results. The use of prophylactic perioperative antimicrobials was defined as concordant if the baseline axillary flora were susceptible to the given antibiotic and discordant if not. As species are the most common pathogen causative for breast implant-related infections, patients colonized with these organisms were analyzed in detail. All patients were followed up for at least 6 months postoperatively and evaluated for SSIs. RESULTS: A total of 238 patients (99%) received both perioperative and postoperative oral antimicrobials. The most common preoperative staphylococci axillary flora recovered were methicillin-sensitive coagulase-negative (67%), methicillin-resistant coagulase-negative (35%), with only 1 case of methicillin-sensitive (0.4%). Thirty-three patients (14%) developed an SSI. Of those with a positive culture, only 54% received a concordant antimicrobial regimen, but this was not associated with an increased risk for infection ( > 0.72). CONCLUSIONS: The use of perioperative antimicrobials whether concordant or discordant with the preoperative axillary microbial flora, specifically species, did not provide a significant impact on the risk of SSI.
未标注:已经采取了几个步骤来降低术后手术部位感染(SSI)的发生率。使用针对患者微生物菌群的预防性抗菌药物与术后感染的减少有关。我们评估了围手术期抗菌药物、基线微生物菌群与SSI发生之间的关系。 方法:我们前瞻性地纳入了2015年9月至2018年1月期间计划接受基于乳房切除术后植入物的重建手术的241例患者。术前获取腋窝拭子培养物,并鉴定所有培养出的细菌。外科医生对这些结果不知情。如果基线腋窝菌群对给定抗生素敏感,则围手术期预防性抗菌药物的使用被定义为一致;如果不敏感,则定义为不一致。由于[具体物种]是乳房植入物相关感染最常见的致病病原体,对定植有这些微生物的患者进行了详细分析。所有患者术后至少随访6个月,并评估是否发生SSI。 结果:共有238例患者(99%)接受了围手术期和术后口服抗菌药物。术前腋窝最常见的葡萄球菌菌群为甲氧西林敏感凝固酶阴性(67%)、甲氧西林耐药凝固酶阴性(35%),仅1例甲氧西林敏感(0.4%)。33例患者(14%)发生了SSI。在培养结果为阳性的患者中,只有54%接受了一致的抗菌方案,但这与感染风险增加无关(P>0.72)。 结论:围手术期抗菌药物的使用,无论与术前腋窝微生物菌群是否一致,特别是[具体物种],对SSI风险没有显著影响。
Plast Reconstr Surg Glob Open. 2019-7-26
Infect Control Hosp Epidemiol. 2013-11-26
J Neurosurg Spine. 2015-4-10
Aesthetic Plast Surg. 2018-2
Plast Reconstr Surg Glob Open. 2016-5-6
Plast Reconstr Surg Glob Open. 2016-6-10